Director Emil Kuriakose filed an initial statement of beneficial ownership with the SEC on November 3, 2026, disclosing no securities held in MacroGenics Inc. as of his October 30, 2026 event date.

Key Highlights

  • Reporting person: Emil Kuriakose, identified as a Director of MacroGenics Inc. (NASDAQ:MGNX).
  • Event date: The date of the event requiring the statement was October 30, 2026.
  • No securities owned: The filing states "No securities are beneficially owned" in both the non-derivative and derivative security tables.
  • Filing date: The statement was filed on November 3, 2026, signed by Beth A. Smith as attorney-in-fact.
  • Individual filing: The form was filed by one reporting person acting alone, not as part of a group.

Kuriakose's Initial Ownership Disclosure at MacroGenics

MacroGenics Inc., a clinical-stage biopharmaceutical company headquartered at 9704 Medical Center Drive, Rockville, Maryland 20850, received an initial beneficial ownership statement from newly appointed Director Emil Kuriakose. According to the filing, the event requiring the statement occurred on October 30, 2026, consistent with Kuriakose's assumption of a director role at the company.

The filing reports no entries in Table I, which covers non-derivative securities such as common stock, nor in Table II, which covers derivative securities such as options, warrants, or convertible instruments. The filing explicitly states "No securities are beneficially owned," meaning Kuriakose disclosed holding neither direct nor indirect interests in any MacroGenics securities as of the event date. The statement was signed by Beth A. Smith as attorney-in-fact on November 3, 2026, the same date it was submitted to the SEC.

MacroGenics is listed on NASDAQ under the ticker symbol MGNX. This type of initial statement is required under Section 16(a) of the Securities Exchange Act of 1934 for directors, officers, and certain shareholders whenever they first become subject to reporting obligations with respect to a public company's securities.

What Was Disclosed

Emil Kuriakose, a newly designated Director at MacroGenics Inc. (NASDAQ:MGNX), filed an initial beneficial ownership statement covering the October 30, 2026 event date, disclosing no direct or indirect holdings in any class of the company's securities.